Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICADNASDAQ:NPCENASDAQ:OMNASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICADiCAD$3.68-2.1%$3.37$1.18▼$4.02$101.09M1.38420,611 shs154,926 shsNPCENeuroPace$11.07-1.4%$12.87$5.45▼$18.98$363.09M2.03169,089 shs503,404 shsOMOutset Medical$19.96-1.6%$15.18$5.85▼$72.60$353.73M2.15118,435 shs338,128 shsSMLRSemler Scientific$29.58-3.8%$35.56$21.77▼$81.56$329.88M1.42509,970 shs649,542 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICADiCAD-2.13%-5.64%-5.88%+60.70%+138.96%NPCENeuroPace-1.42%-15.82%-29.04%+3.55%+59.28%OMOutset Medical-1.58%-4.63%+7.89%+140.63%-71.14%SMLRSemler Scientific-3.77%-10.31%-9.10%-13.89%-27.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationICADiCAD0.974 of 5 stars0.05.00.00.02.80.80.0NPCENeuroPace3.7211 of 5 stars3.45.00.00.02.54.20.6OMOutset Medical1.777 of 5 stars3.53.00.00.01.60.80.0SMLRSemler Scientific2.7357 of 5 stars3.52.00.00.01.82.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICADiCAD 2.00HoldN/AN/ANPCENeuroPace 2.83Moderate Buy$15.5040.02% UpsideOMOutset Medical 3.00Buy$27.0035.27% UpsideSMLRSemler Scientific 3.00Buy$71.00140.03% UpsideCurrent Analyst Ratings BreakdownLatest ICAD, NPCE, SMLR, and OM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025NPCENeuroPaceHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$18.005/21/2025OMOutset MedicalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.005/15/2025OMOutset MedicalScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/14/2025NPCENeuroPaceJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.005/14/2025NPCENeuroPaceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.005/8/2025OMOutset MedicalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.004/17/2025ICADiCADLaidlawSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold4/16/2025ICADiCADBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/16/2025ICADiCADCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/21/2025OMOutset MedicalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$15.00(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICADiCAD$19.53M5.18N/AN/A$1.27 per share2.90NPCENeuroPace$84.31M4.31N/AN/A$0.79 per share14.01OMOutset Medical$115.27M3.07N/AN/A$2.45 per share8.15SMLRSemler Scientific$49.23M6.70$1.75 per share16.95$10.45 per share2.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICADiCAD-$4.85M-$0.19N/A∞N/A-17.81%-15.65%-12.52%8/14/2025 (Estimated)NPCENeuroPace-$32.96M-$0.84N/AN/AN/A-36.74%-205.41%-28.29%8/12/2025 (Estimated)OMOutset Medical-$172.80M-$29.15N/A∞N/A-112.57%-175.64%-38.61%8/6/2025 (Estimated)SMLRSemler Scientific$20.58M-$2.616.02∞N/A72.65%50.77%47.04%8/4/2025 (Estimated)Latest ICAD, NPCE, SMLR, and OM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025ICADiCAD-$0.0625-$0.02+$0.0425-$0.03$4.54 million$4.87 million5/13/2025Q1 2025NPCENeuroPace-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 million5/7/2025Q1 2025OMOutset Medical-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million3/19/2025Q4 2024ICADiCAD-$0.0525-$0.03+$0.0225-$0.03$4.72 million$5.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICADiCADN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICADiCADN/A4.023.91NPCENeuroPace6.035.594.77OMOutset Medical4.126.495.04SMLRSemler ScientificN/A3.143.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICADiCAD24.61%NPCENeuroPace78.83%OMOutset MedicalN/ASMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipICADiCAD10.29%NPCENeuroPace22.20%OMOutset Medical2.40%SMLRSemler Scientific30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICADiCAD14027.47 million23.81 millionOptionableNPCENeuroPace17032.80 million23.22 millionOptionableOMOutset Medical52017.72 million51.50 millionNot OptionableSMLRSemler Scientific12011.15 million6.47 millionNot OptionableICAD, NPCE, SMLR, and OM HeadlinesRecent News About These CompaniesBank of America Corp DE Trims Position in Semler Scientific, Inc. (NASDAQ:SMLR)June 14 at 3:10 AM | marketbeat.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 13 at 5:25 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 13 at 10:15 AM | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Semler Scientific, Inc. (SMLR) And Encourages Shareholders to Reach OutJune 12 at 10:00 AM | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 12 at 9:00 AM | prnewswire.comROSEN, A TOP-RANKED FIRM, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 11 at 9:37 PM | accessnewswire.comTom Lee Mulls Roughed-Up Semler Scientific for 'Granny Shot' PortfolioJune 11 at 4:11 PM | coindesk.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Semler Scientific, Inc. (SMLR) and Encourages Shareholders to Learn More About the InvestigationJune 11 at 10:00 AM | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 11 at 9:00 AM | accessnewswire.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 10, 2025 | prnewswire.comTraders Purchase Large Volume of Semler Scientific Call Options (NASDAQ:SMLR)June 10, 2025 | marketbeat.comSemler Scientific, Inc. (SMLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationJune 10, 2025 | accessnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. ...June 9, 2025 | gurufocus.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 9, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 9, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Semler Scientific, Inc. (SMLR) Shareholders to Inquire about Securities InvestigationJune 9, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Semler Scientific, Inc. (SMLR) And Encourages Investors to ConnectJune 8, 2025 | accessnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You ...June 7, 2025 | bakersfield.comSemler Scientific Inc call volume above normal and directionally bullishJune 7, 2025 | msn.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 7, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 7, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeICAD, NPCE, SMLR, and OM Company DescriptionsiCAD NASDAQ:ICAD$3.68 -0.08 (-2.13%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$3.70 +0.02 (+0.54%) As of 06/13/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.NeuroPace NASDAQ:NPCE$11.07 -0.16 (-1.42%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$11.10 +0.03 (+0.27%) As of 06/13/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Outset Medical NASDAQ:OM$19.96 -0.32 (-1.58%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$19.98 +0.02 (+0.08%) As of 06/13/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Semler Scientific NASDAQ:SMLR$29.58 -1.16 (-3.77%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$29.74 +0.17 (+0.56%) As of 06/13/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
